Ramucirumab
Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors. Ramucirumab is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF-A, VEGF-C, and VEGF-D.
| Catalog Number | R1651 |
| Molecular Formula | C₂₈₅H₄₃₄N₇₄O₈₈S₂ |
| CAS# | 947687-13-0 |
| Purity | >95% |
| Size | Inquiry |
| Supplier Page | https://www.creative-peptides.com/product/ramucirumab-item-r1651-2480.html |